The differences in WBC content and tumor cell recovery between the respective protocols was further reflected by gene expression levels of the leukocyte-specific gene CD45 and the epithelial cell marker gene CK19 (Fig. 2d). The gene discussed is KRT19; the disease is neoplasm.